Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Class-Specific Adverse Events of Patients Treated with Small Interfering RNA Therapeutics: A Disproportionality Analysis of the United States Food and Drug Administration Adverse Event Reporting System Database Based on the MY FAERS Platform.
Journal: Nucleic acid therapeutics
Published: November 22, 2025
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Journal: Frontiers in pharmacology
Published: October 07, 2025
Neurovisceral Syndrome in a Patient with Monoclonal Gammopathy of Undetermined Significance: A Confirmed Case of Variegate Porphyria.
Journal: Cureus
Published: September 19, 2025
Identification of oligonucleotide drug impurities using heart-cutting two-dimensional liquid chromatography-tandem mass spectrometry (2D-LC-MS/MS).
Journal: Analytica chimica acta
Published: May 25, 2025
The Fomivirsen, Patisiran, and Givosiran Odyssey: How the Success Stories May Pave the Way for Future Clinical Translation of Nucleic Acid Drugs.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: February 20, 2025
Development, opportunities, and challenges of siRNA nucleic acid drugs.
Journal: Molecular therapy. Nucleic acids
Published: February 03, 2025
Successful Pregnancy After Combined Liver and Renal Transplantation in a Patient With Acute Intermittent Porphyria.
Journal: Case reports in transplantation
Published: January 08, 2025
Givosiran: a targeted treatment for acute intermittent porphyria.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 07, 2024
Acute Intermittent Porphyria in an Adolescent Patient: Diagnostic and Treatment Challenges.
Journal: Cureus
Published: November 29, 2024
Baseline urinary ALA and PBG as criteria for starting pharmacologic prophylactic treatment in acute intermittent porphyria treated with givosiran.
Journal: Molecular genetics and metabolism reports
Published: October 14, 2024
Efficacy and safety of givosiran in Japanese patients with acute hepatic porphyria: clinical findings from an expanded access study.
Journal: Scientific reports
Published: October 04, 2024
Last Updated: 01/07/2026